Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion
Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business ...
Apollo Heart Valve Clinic at Indraprastha Apollo Hospital (New Delhi) Combines Innovation and Expertise for Better Patient Outcomes
NewsVoir New Delhi [India] 3 Indraprastha Apollo Hospitals proudly announces the launch of its Heart Valve Clinic a dedicated ...
Edwards Lifesciences upped to Buy at Stifel on TAVR growth
Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.
devdiscourse1d
Apollo Hospitals Launches Heart Valve Clinic: A New Era in Cardiac Care
Indraprastha Apollo Hospitals has launched a Heart Valve Clinic, offering advanced care for heart valve disorders. The clinic boasts cutting-edge technology and a multidisciplinary team for ...
Edwards Lifesciences Q4 Earnings Set to Benefit From TAVR Growth
Favorable hospitalization trend, strong adoption of transcatheter heart valves and improved procedural volume are expected to have aided EW in the fourth quarter.
Edwards Lifesciences Corporation (EW): A Bull Case Theory
We came across a bullish thesis on Edwards Lifesciences Corporation (EW) on Substack by Natan. In this article, we will ...
Healio4d
CABG plus surgical AVR may suit certain older patients with aortic stenosis, CAD
CABG plus surgical aortic valve replacement for treatment of coronary disease and aortic stenosis was associated with better 5-year outcomes vs. PCI plus transcatheter aortic valve replacement in ...
Healio16h
Top in cardiology: Heart disease remains leading cause of death; low-value aspirin use
The American Heart Association has issued its heart disease and stroke statistical update for 2025, which provides an ...
Edwards Lifesciences upgraded to Buy from Hold at Stifel
Stifel analyst Rick Wise upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said that TAVR, ...
Pharmabiz5d
Abbott introduces Navitor Vision in India, the next generation of heart valve technology designed to treat aortic stenosis
Our Bureau, Mumbai Thursday, January 30, 2025, 15:15 Hrs [IST] ...
expresshealthcare6d
Abbott launches Navitor Vision Valve in India for high-risk aortic stenosis patients
Navitor Vision enhances visibility and precision in TAVI procedures, offering a less invasive alternative to surgical aortic ...
Stifel raises Edwards Lifesciences stock to buy, target to $90
Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also ...